pharma · Congenital Adrenal Hyperplasia · Carcinoid Syndrome · CRNX
Crinetics Pharmaceuticals Europe
Crinetics Pharmaceuticals Europe GmbH
Crinetics Pharmaceuticals Europe clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
6055 Lusk Blvd, San Diego, California 92121, US HQ
2008 Founded
597 Employees
Public company Type
CRNX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 6055 Lusk Blvd, San Diego, California 92121, US
- Founded
- 2008
- Employees
- 597
- Programs
- 12
- Drugs
- 4
- Patents
- 26
Crinetics Pharmaceuticals Europe projects
0 ClinicalTrials.gov programs sponsored by Crinetics Pharmaceuticals Europe.
Crinetics Pharmaceuticals Europe has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Crinetics Pharmaceuticals Europe have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.